Impulse Biomedical is a Cape Town based South African med‑tech company that specialises in developing affordable, user centric medical devices designed to improve access to essential healthcare technologies. With a mission to break down barriers to quality care, the company focuses on creating innovative solutions that address real‑world health challenges such as asthma and severe allergic reactions. Its approach centres on designing low‑cost, high performing devices that are easier to use and more accessible for patients of all ages, particularly those in underserved communities.
The company’s product portfolio includes flagship innovations such as Easy Squeezy an ergonomic asthma inhaler assist device that significantly reduces the effort required to operate traditional pumps and the ZiBiPen, the world’s first re-loadable epinephrine auto‑injector meant to make allergy emergency care more sustainable and affordable. Backed by strategic investments from impact‑focused investors, Impulse Biomedical continues to advance its technologies toward broader commercialisation and international deployment, aiming to bring life saving healthcare solutions to patients both locally in South